Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's Disease

Clinical trial NCT02038920 · COMPLETED

Trial details

NCT number: NCT02038920
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2014-01-28
Primary completion: 2019-01-25
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.